AnGes Inc

AJW

Company Profile

  • Business description

    AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

  • Contact

    7-7-15, Saito-asagi
    4F, Saito Bio-Incubator
    Ibaraki
    Osaka567-0085
    JPN

    http://www.anges.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    71

Stocks News & Analysis

stocks

10 best US growth stocks to buy for the long term

The stocks of these high-quality growth companies look undervalued today.
stocks

Higher fair value for overvalued ASX tech share

Underlying secular growth stronger than we thought.
stocks

Nvidia: Collaboration with Intel might bring some goodwill with the US

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.1011.700.13%
CAC 407,834.6118.98-0.24%
DAX 4023,487.07152.34-0.64%
Dow JONES (US)46,315.27172.850.37%
FTSE 1009,224.898.220.09%
HKSE26,344.14200.96-0.76%
NASDAQ22,631.48160.750.72%
Nikkei 22545,493.66447.850.99%
NZX 50 Index13,141.5490.12-0.68%
S&P 5006,664.3632.400.49%
S&P/ASX 2008,810.9011.400.13%
SSE Composite Index3,828.588.490.22%

Market Movers